Mainz Biomed Company Description

Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States.

The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer.

It has a collaboration agreement with Thermo Fisher Scientific Inc. for the development of colorectal cancer screening product.

The company was founded in 2008 and is based in Mainz, Germany.

Mainz Biomed N.V.

Country	Netherlands
Founded	2008
Industry	In Vitro and In Vivo Diagnostic Substances
Employees	71
CEO	Guido Baechler

Contact Details

Address: Robert Koch Strasse 50 Mainz, 55129 Germany
Phone	49 6131 554 2860
Website	mainzbiomed.com

Stock Details

Ticker Symbol	4TO
Exchange	Stuttgart Stock Exchange
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2835

Key Executives

Name	Position
Guido Baechler	Chief Executive Officer
William Caragol	Chief Financial Officer
Christopher Von Torne	Chief Operating Officer